Maria Frånlund awarded the prize for she has increased awareness of PSA-based screening for prostate cancer. The results from this research will contribute to the design of future effective screening programmes.
Mary's research on optimization of start and stop age of PSA screening for possible future screening programmes shows that we can get a reduction of deaths from prostate cancer by 30 percent. This research is an important contribution to the knowledge of the benefits of PSA screening.
Mikael Montelius awarded the prize because he demonstrated the possibility of using advanced magnetic resonance methods to study the characteristics of tumor tissues before and soon after a radiation treatment. The results from this research can contribute to safer early evaluation of the efficacy of a treatment for a patient.
Michael's research is increasing our understanding of radiation effects in tumor tissue which provides opportunities for early detection and allow adjustments of ineffective cancer treatment.
From "Reasons to 2019-Award"
Ceremony's date och place:
The presentation will be done in Swedish.
For more information, please contact: